Amongst other novel formats, non-antibody protein scaffolds have emerged as viable alternatives to conventional therapies, having the capability to address the existing challenges associated with classical antibody based therapies. The ‘Non-Antibody Protein Scaffolds Market‘ report provides a comprehensive study of the current market landscape , and related drugs and diagnostics, featuring an elaborate discussion on the likely future